AI Article Synopsis

  • Ceritinib (CER) is a third-generation tyrosine kinase inhibitor approved for treating ALK-positive non-small-cell lung cancer (NSCLC) but lacks a green, high-throughput method for quantification in its dosage form (Zykadia capsules).
  • Two novel one-step green microwell spectrophotometric methods (MW-SPMs) were developed to quantify CER using colored derivatives produced by reactions with two different benzoquinone reagents: OBQ and DDQ, utilizing distinct reaction mechanisms.
  • The methods were validated for reliability, optimized for high throughput with limits of quantitation established, and shown to meet green analytical standards, allowing efficient simultaneous analysis of multiple samples.

Article Abstract

Ceritinib (CER) is a potent drug of the third-generation tyrosine kinase inhibitor class. CER has been approved for the treatment of patients with non-small-cell lung cancer (NSCLC) harboring the anaplastic lymphoma kinase (ALK) mutation gene. In the literature, there is no green and high-throughput analytical method for the quantitation of CER in its dosage form (Zykadia capsules). This study describes, for the first time, the development and validation of two novel one-step and green microwell spectrophotometric methods (MW-SPMs) for the high-throughput quantitation of CER in Zykadia capsules. These two methods were based on an formation of colored derivatives upon the reaction of CER with two different benzoquinone reagents via two different mechanisms. These reagents were -benzoquinone (OBQ) and 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (DDQ), and their reactions proceeded via condensation and charge transfer reactions, respectively. The reactions were carried out in 96-well transparent plates, and the absorbances of the colored reaction products were measured with an absorbance microplate reader at 540 and 460 nm for reactions with OBQ and DDQ, respectively. The optimum conditions of reactions were established, their molar ratios were determined, and reaction mechanisms were postulated. Under the refined optimum reaction conditions, procedures of MW-SPMs were established and validated according to the guidelines of the International Council on Harmonization. The limits of quantitation were 6.5 and 10.2 µg/well for methods involving reactions with OBQ and DDQ, respectively. Both methods were applied with great reliability to the determination of CER content in Zykadia capsules and their drug uniformity. Greenness of the MW-SPMs was evaluated using three different metric tools, and the results proved that the two methods fulfil the requirements of green analytical approaches. In addition, the simultaneous handling of a large number of samples with microvolumes in the proposed methods gave them the advantage of a high-throughput analysis. : The two methods are valuable tools for rapid routine application in pharmaceutical quality control units for the quantitation of CER.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608039PMC
http://dx.doi.org/10.3390/medicina59101813DOI Listing

Publication Analysis

Top Keywords

quantitation cer
12
zykadia capsules
12
novel one-step
8
one-step green
8
green microwell
8
microwell spectrophotometric
8
methods
8
spectrophotometric methods
8
potent drug
8
anaplastic lymphoma
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!